Table 2. Summary of differences in titre steps (Δ titre steps) of neutralising antibodies against HPV 6, HPV 16, and HPV 18 in paired sera and oral fluids after HPV vaccination.
| Vaccinees Δ titre steps (oral fluids) | Controls Δ titre steps (oral fluids) | |||||||
|---|---|---|---|---|---|---|---|---|
|
HPV 6 | ||||||||
| Δ Titre steps (sera) | 1 | 0 | −1 | Total | 1 | 0 | −1 | Total |
| 0 | 2 | 0 | 0 | 2 | 0 | 11 | 3 | 14 |
| 1 | 4 | 7 | 2 | 13 | 0 | 0 | 0 | 0 |
| 2 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
| 3 | 0 | 3 | 0 | 3 | 0 | 0 | 1 | 1 |
| Total | 7 | 11 | 2 | 20 | 0 | 11 | 3 | 14 |
|
HPV 16 | ||||||||
| Δ Titre steps (sera) | 2 | 1 | 0 | Total | 2 | 1 | 0 | Total |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 14 |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 0 | 3 | 7 | 10 | 0 | 0 | 0 | 0 |
| 3 | 0 | 8 | 2 | 10 | 0 | 0 | 0 | 0 |
| Total | 0 | 11 | 9 | 20 | 0 | 0 | 14 | 14 |
|
HPV 18 | ||||||||
| Δ Titre steps (sera) | 2 | 1 | 0 | Total | 2 | 1 | 0 | Total |
| 0 | 0 | 0 | 1 | 1 | 0 | 1 | 13 | 14 |
| 1 | 1 | 1 | 3 | 5 | 0 | 0 | 0 | 0 |
| 2 | 0 | 4 | 6 | 10 | 0 | 0 | 0 | 0 |
| 3 | 1 | 1 | 2 | 4 | 0 | 0 | 1 | 1 |
| Total | 2 | 6 | 12 | 20 | 0 | 1 | 13 | 14 |